A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose

Recent Research Advances in Selective Matrix Metalloproteinase‐13

Rigidified Bis(sulfonyl)ethylenes as Effective Michael Acceptors

Recent Research Advances in Selective Matrix Metalloproteinase‐13

Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc

Aggrecan in Cardiovascular Development and Disease - Christopher D

Molecules, Free Full-Text

WO2017211666A1 - 5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine

From DEL Selections to Validated Hits to Clinical Leads

A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and

Full article: Advances in the development of novel aggrecanase

Recent Research Advances in Selective Matrix Metalloproteinase‐13

Inhibition of aggrecanases as a therapeutic strategy in